Sorafenib tosylateMeSH concept

http://www.has-sante.fr/portail/jcms/c_2044336/fr/nexavar
http://www.has-sante.fr/portail/jcms/c_2044336/fr/nexavar-sorafenib-inhibiteur-de-proteine-kinase
2015
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
insurance, health, reimbursement
treatment outcome
administration, oral
sorafenib tosylate
sorafenib tosylate
sorafenib
protein kinase inhibitors
protein kinase inhibitors
survival analysis
neoplasm metastasis
thyroid carcinoma
quality of life
thyroid neoplasms
phenylurea compounds
niacinamide
niacinamide
phenylurea compounds
niacinamide
Sorafenib
Sorafenib

---
https://www.ema.europa.eu/medicines/human/EPAR/Nexavar
2012
false
United Kingdom
English
French
phenylurea compounds
phenylurea compounds
niacinamide
syndication feed
treatment outcome
drug evaluation
orphan drug production
carcinoma, renal cell
pyridines
benzenesulfonates
antineoplastic agents
protein kinase inhibitors
sorafenib
pyridines
benzenesulfonates
antineoplastic agents
protein kinase inhibitors
sorafenib tosylate
sorafenib tosylate
drug evaluation
summary of product characteristics
package leaflet
Sorafenib
Sorafenib

---
http://www.msss.gouv.qc.ca/sujets/organisation/lutte-contre-le-cancer/documents/guides-cepo-pdf/CEPO-Guide_utilisation_Sorafenib_cancer_du_rein_m%C3%A9tastatique_(2010-11-15).pdf
2010
false
false
Canada
French
phenylurea compounds
niacinamide
carcinoma, renal cell
neoplasm metastasis
Evidence-Based medicine
receptors, vascular endothelial growth factor
raf kinases
treatment outcome
antineoplastic combined chemotherapy protocols
survival analysis
quality of life
sorafenib
benzenesulfonates
pyridines
antineoplastic agents
protein kinase inhibitors
sorafenib tosylate
guidelines for drug use
Sorafenib

---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/nexavar-795.html
2010
false
Canada
English
French
phenylurea compounds
niacinamide
evaluation of the transparency committee
carcinoma, hepatocellular
pyridines
benzenesulfonates
antineoplastic agents
protein kinase inhibitors
quebec
tablets
insurance, health, reimbursement
administration, oral
treatment outcome
drug costs
sorafenib
sorafenib tosylate
drug evaluation
Sorafenib

---
https://www.jle.com/fr/revues/medecine/bdc/e-docs/00/04/46/C8/resume.phtml?type=text.html
2009
false
France
French
journal article
phenylurea compounds
niacinamide
Tyrosine Kinase Inhibitors
benzenesulfonates
pyridines
Hand-Foot syndrome
antineoplastic agents
sorafenib
administration, oral
protein kinase inhibitors
sorafenib tosylate
receptors, vascular endothelial growth factor
kidney neoplasms
carcinoma, hepatocellular
receptors, platelet-derived growth factor
raf kinases
paresthesia
erythema
Sorafenib

---
http://www.meddispar.fr/medicaments/3761372
2008
false
France
French
phenylurea compounds
niacinamide
pyridines
drug prescriptions
legislation, drug
tablets
benzenesulfonates
administration, oral
continuity of patient care
drug monitoring
sorafenib
sorafenib tosylate
drug information
Sorafenib

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Nexavar_Fe-28-07_f.pdf
2007
false
Canada
French
phenylurea compounds
niacinamide
kidney neoplasms
carcinoma
benzenesulfonates
antineoplastic agents
pyridines
sorafenib
sorafenib tosylate
drug evaluation
Sorafenib

---